Cited by 330Opioid Use Disorder TreatmentPoisoning and overdose treatmentsSubstance Abuse Treatment and Outcomes

The DOI matches its Crossref record; 54 of the 57 references it cites were found in a registry or an index; 1 of the 40 sources its claims cite were checked for support.

National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009.

Open access
Calcaterra, Susan, Glanz, Jason, Binswanger, Ingrid A.·2013·Drug and Alcohol Dependence

Abstract

Background Pharmaceutical opioid related deaths have increased. This study aimed to place pharmaceutical opioid overdose deaths within the context of heroin, cocaine, psychostimulants, and pharmaceutical sedative hypnotics examine demographic trends, and describe common combinations of substances involved in opioid related deaths.Methods We reviewed deaths among 15-64 year olds in the US from 1999-2009 using death certificate data available through the CDC Wide-Ranging Online Data for Epidemiologic Research (WONDER) Database. We identified International Classification of Disease-10 codes describing accidental overdose deaths, including poisonings related to stimulants, pharmaceutical drugs, and heroin. We used crude and age adjusted death rates (deaths/100,000 person years [p-y] and 95% confidence interval [CI] and multivariable Poisson regression models, yielding incident rate ratios; IRRs), for analysis.Results The age adjusted death rate related to pharmaceutical opioids increased almost 4-fold from 1999 to 2009 (1.54/100,000 p-y [95% CI 1.49-1.60] to 6.05/100,000 p-y [95% CI 5.95-6.16; p<0.001). From 1999 to 2009, pharmaceutical opioids were responsible for the highest relative increase in overdose death rates (IRR 4.22, 95% CI 3.03-5.87) followed by sedative hypnotics (IRR 3.53, 95% CI 2.11-5.90). Heroin related overdose death rates increased from 2007 to 2009 (1.05/100,000 persons [95% CI 1.00-1.09] to 1.43/100,000 persons [95% CI 1.38-1.48; p<0.001). From 2005-2009 the combination of pharmaceutical opioids and benzodiazepines was the most common cause of polysubstance overdose deaths (1.27/100,000 p-y (95% CI 1.25-1.30).Conclusion Strategies, such as wider implementation of naloxone, expanded access to treatment, and development of new interventions are needed to curb the pharmaceutical opioid overdose epidemic.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.drugalcdep.2012.11.018

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

40 Own result · 24 Not checked yet · 12 Own method · 5 Own interpretation · 3 No basis given · 1 Supported so far

Verify all 39 references — free account
  • It may state two separate claims as one. 27
  • Probably not a substantial claim. 20
  • The quote only partly states this claim. 1
41 of 41

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 57 references

Cited by

Sorted by citations

See all 330

Metadata

Authors
Calcaterra, S., Glanz, J., & Binswanger, I. A.
Affiliations
  • Denver Health Medical Center (US)
  • Kaiser Permanente (US)
Corresponding author
Calcaterra, Susan
Venue
Drug and Alcohol Dependence
Publisher
Elsevier BV
Published
2013-08
Volume
131
Issue
3
Pages
263-270
ISSN
0376-8716 (ISSN-L)
OpenAlex
W2074807110
Cited by
330
References
57
Citations by year
2026: 2 · 2025: 7 · 2024: 8 · 2023: 21 · 2022: 16 · 2021: 28 · 2020: 24 · 2019: 31 · 2018: 30 · 2017: 51 · 2016: 38 · 2015: 35 · 2014: 31 · 2013: 8
FWCI
38.18
Type
journal article
Language
en
Open access
Locations
  • Drug and Alcohol Dependence (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute on Drug Abuse (R21DA031041)
  • National Institute of Allergy and Infectious Diseases (K01AI073295)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
benzodiazepines, opioid epidemic, age-adjusted death rates, demographic trends, drug overdose deaths, death certificates, ICD-10
MeSH terms
Adolescent, Adult, Cause of Death, Female, Humans, Male, Middle Aged, Naloxone, Opioid-Related Disorders, Retrospective Studies, United States, Databases, Factual, Substance-Related Disorders, Prescription Drugs, Young Adult, Drug Overdose

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (prompt extract-v3).

A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review